HD

Hirak Deb Mazumder

Active Director Director DIN 09082137
DIN 09082137 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value •••• Premium profile

About Hirak Deb Mazumder

Data last updated:

Hirak Deb Mazumder is a Director at Amgeon Pharmaceutical Private Limited (since 2021). The company operates in Pharma. Amgeon Pharmaceutical Private Limited reported revenue of ₹9.1 Lakh (FY 2023).

DIN 09082137
Primary Designation Director
Industry Pharma
First Appointment 27 Feb 2021
Oldest Company Age 6 yrs
Largest company Amgeon Pharmaceutical Private Limited · ₹9.1 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Feb 20212020₹9.1 Lakh (FY 2023)Active

Board colleagues of Hirak Deb Mazumder

Directorship timeline

Open interactive timeline →
Amgeon Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Hirak Deb Mazumder

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hirak Deb Mazumder

Hirak Deb Mazumder currently holds 1 directorship: Amgeon Pharmaceutical Private Limited (Director, since 27 Feb 2021, revenue ₹9.1 Lakh (FY 2023)).

Hirak Deb Mazumder was first appointed on 27 Feb 2021 as Director at Amgeon Pharmaceutical Private Limited.

The current boards of Hirak Deb Mazumder's companies include Hussain Ahmed Barbhuiya (Amgeon Pharmaceutical Private Limited), Rouji Aktar Barlaskar (Amgeon Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available